Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
83
AHCO Quote, Financials, Valuation and Earnings
Last price:
$10.25
Seasonality move
:
-1.26%
Day range:
$10.08 - $10.33
52-week range:
$7.11 - $11.63
Dividend yield:
0%
P/E ratio:
18.79x
P/S ratio:
0.43x
P/B ratio:
0.86x
Volume:
431.3K
Avg. volume:
1.1M
1-year change:
1.89%
Market cap:
$1.4B
Revenue:
$3.3B
EPS (TTM):
$0.55
Analysts' Opinion
-
Consensus RatingAdaptHealth Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $13.25, AdaptHealth Corp. has an estimated upside of 29.4% from its current price of $10.24.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $10.50 representing 100% downside risk from its current price of $10.24.
Fair Value
-
According to the consensus of 7 analysts, AdaptHealth Corp. has 29.4% upside to fair value with a price target of $13.25 per share.
AHCO vs. S&P 500
-
Over the past 5 trading days, AdaptHealth Corp. has underperformed the S&P 500 by -3.67% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
AdaptHealth Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
AdaptHealth Corp. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter AdaptHealth Corp. reported revenues of $820.3M.
Earnings Growth
-
AdaptHealth Corp. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter AdaptHealth Corp. reported earnings per share of $0.16.
Enterprise value:
3.2B
EV / Invested capital:
0.91x
Price / LTM sales:
0.43x
EV / EBIT:
13.26x
EV / Revenue:
0.99x
PEG ratio (5yr expected):
--
EV / Free cash flow:
15.10x
Price / Operating cash flow:
6.55x
Enterprise value / EBITDA:
4.86x
Gross Profit (TTM):
$587.5M
Return On Assets:
1.79%
Net Income Margin (TTM):
2.44%
Return On Equity:
5.03%
Return On Invested Capital:
2.19%
Operating Margin:
8.04%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $3.1B | $3.3B | $3.3B | $805.9M | $820.3M | |
| Gross Profit | $338.3M | $482.2M | $587.5M | $112.7M | $151.8M | |
| Operating Income | $162.9M | $289.8M | $242.7M | $71.9M | $65.9M | |
| EBITDA | $641.2M | $697.5M | $662.7M | $172.9M | $175.1M | |
| Diluted EPS | -$3.35 | -$1.65 | $0.55 | $0.15 | $0.16 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $823.4M | $631.9M | $585.1M | $683.8M | $724.8M | |
| Total Assets | $5.2B | $5.2B | $4.7B | $4.5B | $4.4B | |
| Current Liabilities | $502.1M | $466.9M | $448.2M | $553M | $670.7M | |
| Total Liabilities | $3.2B | $3.1B | $3B | $2.9B | $2.8B | |
| Total Equity | $2B | $2.2B | $1.7B | $1.5B | $1.6B | |
| Total Debt | $2.4B | $2.3B | $2.3B | $2.1B | $1.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $422.3M | $546.7M | $569M | $144.4M | $161.1M | |
| Cash From Investing | -$412.7M | -$313.8M | -$265.6M | -$54.2M | -$92.7M | |
| Cash From Financing | -$64.3M | -$188.8M | -$323.2M | -$59.8M | -$56.6M | |
| Free Cash Flow | $30.6M | $229.3M | $213.2M | $84.8M | $66.8M | |
AHCO
Sector
Market Cap
$1.4B
$28M
Price % of 52-Week High
88.05%
51.03%
Dividend Yield
0%
0%
Shareholder Yield
5.26%
-1.54%
1-Year Price Total Return
1.89%
-17.48%
Beta (5-Year)
1.768
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$10.28
200-day SMA
Buy
Level
$9.26
Bollinger Bands (100)
Buy
Level
8.97 - 9.83
Chaikin Money Flow
Sell
Level
-30.9M
20-day SMA
Buy
Level
$9.90
Relative Strength Index (RSI14)
Buy
Level
57.19
ADX Line
Buy
Level
37.93
Williams %R
Neutral
Level
-27.881
50-day SMA
Buy
Level
$9.59
MACD (12, 26)
Buy
Level
0.22
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
11.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.0586)
Sell
CA Score
(Annual)
Level (-0.6814)
Buy
Beneish M-Score
(Annual)
Level (-3.2256)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-3.9571)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Conshohocken, PA.
Stock Forecast FAQ
In the current month, AHCO has received 5 Buy ratings 2 Hold ratings, and 0 Sell ratings. The AHCO average analyst price target in the past 3 months is $13.25.
-
Where Will AdaptHealth Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that AdaptHealth Corp. share price will rise to $13.25 per share over the next 12 months.
-
What Do Analysts Say About AdaptHealth Corp.?
Analysts are divided on their view about AdaptHealth Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that AdaptHealth Corp. is a Sell and believe this share price will drop from its current level to $10.50.
-
What Is AdaptHealth Corp.'s Price Target?
The price target for AdaptHealth Corp. over the next 1-year time period is forecast to be $13.25 according to 7 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is AHCO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for AdaptHealth Corp. is a Buy. 5 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of AHCO?
You can purchase shares of AdaptHealth Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase AdaptHealth Corp. shares.
-
What Is The AdaptHealth Corp. Share Price Today?
AdaptHealth Corp. was last trading at $10.25 per share. This represents the most recent stock quote for AdaptHealth Corp.. Yesterday, AdaptHealth Corp. closed at $10.24 per share.
-
How To Buy AdaptHealth Corp. Stock Online?
In order to purchase AdaptHealth Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get AHCO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AHCO
Sector
P/E ratio
18.79x
23.89x
PEG ratio
--
-0.01x
P/B ratio
0.86x
1.82x
Price / LTM sales
0.43x
1.60x
Growth Metrics
AHCO
Sector
Revenue growth
1.79%
4.62%
Earnings growth
6.72%
10.88%
Revenue (5-year growth)
43.84%
6.5%
Earnings forecast
$0.24
-$0.21
Profitability
AHCO
Sector
Profitability FY 2024
$636M
$3.5M
Return on invested capital
2.19%
-31.77%
Return on assets
1.79%
-27.96%
Return on equity
5.03%
-37.63%
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Feb
24
Estimated Next Earnings Date
Feb
3
Balance Sheet
AHCO
Sector
Total cash
$80.4M
$26.3M
Short term investments
--
$25.7M
Total assets
$4.6B
$78M
Long term debt
$1.9B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
